Effects of short-term treatment with pravastatin on the hepatic synthesis of cholesterol and bile acids in gallstone patients

European Journal of Clinical Investigation

Volumn 28, Issue 4, 1998, Pages 324-328

  Hillebrant, C G ^a   Axelson, M ^a   Bjorkhem I ^a   Wang, F H ^a   Nyberg, B ^a   Einarsson, C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bile acid synthesis; Cholesterol synthesis; Cholesterol synthesis inhibitor; Gallstone disease; Hypercholesterolaemia; Plasma lipoproteins

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; BILE SECRETION; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; FEMALE; GALLSTONE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; BILIRUBIN; CHOLECYSTECTOMY; CHOLELITHIASIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; MALE; MIDDLE AGED; PRAVASTATIN; TRIGLYCERIDES;

EID: 0031976787     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00288.x     Document Type: Article

References (31)

1. Kovanen PT, Bilheimer DW, Goldstein JL, Jaramillo JJ, Brown MS. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA 1981; 78: 1194-8.
2. Ma PT, Gil G, Südhof TC, Bilheimer DW, Goldstrom JL, Brown MS. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptors in livers of hamsters and rabbits. Proc Natl Acad Sci USA 1986; 83: 8370-4.
3. Tobert JA, Bell GD, Birtwell J et al. Cholesterol lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A in healthy volunteers. J Clin Invest 1982; 69: 913-9.
4. Grundy SM. HMG-CoA reductance inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988; 319: 24-33.
5. Vanhanen H, Kesäniemi YA, Miettinen TA. Pravastatin lowers serum cholesterol, cholesterol- precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 1992; 41: 588-95.
6. Duane WC. Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects. J Clin Invest 1993; 92: 911-8.
7. Grundy SM, Bilheimer DW. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: Effects on cholesrerol balance. Proc Natl Acad Sci USA 1984; 81: 2538-42.
8. Reihnér E, Rudling M, Ståhlberg D et al. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase on hepatic metabolism of cholesterol. N Engl J Med 1990; 323: 224-8.
9. Mitchell JC, Logan JM, Stone BG, Duane WC. Effects of lovastatin on biliary lipid secretion and bife acid metabolism in humans. J Lipid Res 1991; 32: 71-8.
10. Muraca M, Baggio G, Miconi L et al. Acute effects of HMG-CoA reductase inhibitors on biliary lipids in patients with interrupted enterohepatic circulation. Eur J Clin Invest 1991; 21: 204-8.
11. Bertolotti M, Abate N, Loria P et al. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α-hydroxylation rates in vivo. Hepatalogy 1991; 14: 830-7.
12. Mitchell JC, Stone BG, Logan GM, Duane WC. Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 1991; 32: 1143-9.
13. Mazella G, Parini P, Festi D et al. Effects of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in non-familial hypercholesterolemia. Hepatology 1992; 15: 1072-8.
14. Duane WC. Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy subjects. J Lipid Res 1994; 35: 501-9.
15. Loria P, Bertolotti M, Cassinadri MT et al. Short term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects. Hepatology 1994; 19: 882-8.
16. Björkhem I, Miettinen T, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG CoA reductase in human liver. J Lipid Res 1987; 28: 1137-43.
17. Axelson M, Björkhem I, Reihnér E, Einarsson K. The plasma level of 7α-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7α-hydroxylase in man. FEBS Lett 1991; 284: 216-8.
18. Carlson K. Lipoprotein fractionation. J Clin Pathol 1973; 26 (Suppl. 5): 32-7.
19. Lopez-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-4.
20. Lund E, Sisfonte L, Reihner E, Björkhem I. Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry. Stand J Clin Lab Invest 1989; 49: 165-71.
21. Axelson M, Aly A, Sjövall J. Levels of 7α-hydroxy-4-cholesten-3-one in plasma reflect rates of bile acid synthesis in man. FEBS Lett 1988; 239: 324-8.
22. Kempen JHM, Glatz JFC, Gevers-Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988; 29: 1144-55.
23. Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7α-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 1996; 26: 1160-5.
24. Hillebrant C-G, Eriksson M, Nyberg B, Einarsson C. Changes in biliary lipid output after interruption of pravastatin treatment in humans. Eur J Clin Invest 1996; 26: 1160-5.
25. Einarsson K, Reihnér E, Björkhem I. On the saturation of the cholesterol 7α- hydroxylase in human liver microsomes. J Lipid Res 1989; 30: 1477-81.
26. Axelson M, Sjövall J. Potential bias acid precursors in plasma: possible indicators of biosynthetic ways to cholic and chenodeoxycholic acids in man. J Steroid Biochem 1990; 36: 631-40.
27. Princen HMG, Meijer P, Wolthers BG, Vonk RJ, Kuipers F. Cyclosporine A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. Biochem J 1991; 275: 501-5.
28. Björkhem I, Nyberg B, Einarsson K. 7α-hydroxylation of 27-hydroxycholesterol in human liver microsomes. Biochim Biophys Acta 1992; 1128: 73-6.
29. Shoda J, Toll A, Axelson M, Pieper F, Wikvall K, Sjövall J. Formation of 7α- and 7β-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria. Hepatology 1993; 17: 395-403.
30. Dahlbäck-Sjöberg H, Björkhem I, Princen HMG. Selective inhibition of mitochondrial 27-hydroxylation of bile acid intermediates and 25-hydroxylation of vitamin D3 by cyclosporin A. Biochem J 1993; 293: 203-6.
31. Javitt N. Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. FASEB J 1994; 8: 1308-11.